These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2354287)

  • 61. HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection.
    Varnier OE; Lillo F; Alexander SS; Forbis RM; Present W; Lazzarin A
    JAMA; 1991 Feb; 265(5):597. PubMed ID: 1987408
    [No Abstract]   [Full Text] [Related]  

  • 62. FDA approval of HTLV-I tests.
    Montagna RA
    Science; 1989 Jan; 243(4887):12. PubMed ID: 2911713
    [No Abstract]   [Full Text] [Related]  

  • 63. HIV-1 and HTLV-1 infections among intravenous drug abusers in Belgrade, Yugoslavia.
    Cobic P; Keserovic N; Radovanovic Z; Dobec M; Bjeljac ZS; Jung M; Prelic A; Vukov M; Baba-Milkic N; Gledovic Z
    J Acquir Immune Defic Syndr (1988); 1990; 3(12):1197-9. PubMed ID: 2243321
    [No Abstract]   [Full Text] [Related]  

  • 64. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence and molecular characterization of human T cell leukemia virus type 2 in a group of intravenous drug users coinfected with HIV type 1 in Portugal.
    Silva AF; Almeida C; Martins HC; Coutinho R; Leitão E; Silva R; Paixão MT; Pádua E
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):249-55. PubMed ID: 15943566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prescribing syringes to injection drug users with HIV: an important clinical and public health tool.
    Stozek MA; Taylor LE; LeBreux L; Olson J; Wolf F; Rich JD
    J Assoc Nurses AIDS Care; 2004; 15(2):59-63. PubMed ID: 15090134
    [No Abstract]   [Full Text] [Related]  

  • 67. [HTLV-I infection in sailors who travel to sub-Saharan West Africa].
    Pujol E; Ollero M; Márquez P; Gea A; Alcoucer R; Gimeno A
    Enferm Infecc Microbiol Clin; 1991 May; 9(5):283-5. PubMed ID: 1954264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transmission routes of HTLV-I: an analysis of 66 families.
    Take H; Umemoto M; Kusuhara K; Kuraya K
    Jpn J Cancer Res; 1993 Dec; 84(12):1265-7. PubMed ID: 8294217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
    Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
    Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood donor HTLV-1 antibody testing.
    Menitove JE
    Transfusion; 1989 Jan; 29(1):1-2. PubMed ID: 2643208
    [No Abstract]   [Full Text] [Related]  

  • 73. Risk behaviour and HTLV-1 seropositivity in injecting drug users.
    Rezza G; Lazzarin A; Uberti-Foppa C; Tumbarello M; Menniti-Ippolito F; Pezzotti P; Titti F; Verani P
    Br J Addict; 1990 May; 85(5):686-7. PubMed ID: 2354287
    [No Abstract]   [Full Text] [Related]  

  • 74. Risk factors for human T cell lymphotropic virus type I among injecting drug users in northeast Brazil: possibly greater efficiency of male to female transmission.
    Dourado I; Andrade T; Carpenter CL; Galvão-Castro B
    Mem Inst Oswaldo Cruz; 1999; 94(1):13-8. PubMed ID: 10029907
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
    Page JB; Lai SH; Chitwood DD; Klimas NG; Smith PC; Fletcher MA
    Lancet; 1990 Jun; 335(8703):1439-41. PubMed ID: 1972217
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain.
    Calderón EJ; Gómez-Lucia E; Aguado I; Pineda JA; Essex M; Leal M
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):773-5. PubMed ID: 1810736
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.